---
title: "Top Executives Quietly Unload Sera Prognostics Shares in Back-to-Back Moves"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289408699.md"
description: "Sera Prognostics (SERA) executives sold shares in June 2026: CEO Zhenya Lindgardt offloaded 20,755 shares for $43,170, and CFO Austin Aerts sold 5,440 shares for $11,315. This insider selling coincides with governance stability updates. Despite optimism over the PreTRM test and PRIME study, SERA holds a 'Neutral' rating due to weak financials, cash burn, and negative YTD performance of -27.80%."
datetime: "2026-06-11T02:09:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289408699.md)
  - [en](https://longbridge.com/en/news/289408699.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289408699.md)
generator: "portal-rs"
---

# Top Executives Quietly Unload Sera Prognostics Shares in Back-to-Back Moves

New insider activity at Sera Prognostics ( (SERA) ) has taken place on June 10, 2026.

Sera Prognostics has seen notable insider selling activity, with CEO Zhenya Lindgardt offloading 20,755 shares of company stock in a transaction valued at $43,170. In a separate move, CFO Austin Aerts sold 5,440 shares of Sera Prognostics stock, generating proceeds of $11,315. These transactions highlight recent share disposals by two of the company’s top executives and may draw investor attention to insider sentiment and trading patterns at Sera Prognostics.

Sera Prognostics’ stock has seen attention after its annual meeting confirmed board and audit continuity while also managing a planned director resignation, which collectively supports a message of governance stability during a leadership transition. Analysts’ recent price targets are driven by optimism over the company’s proprietary PreTRM test and the landmark PRIME study, which are expected to accelerate payer coverage and adoption in a large preterm birth market, partly offset by concern over weak current revenues, cash burn, and bearish technicals that limit near‑term valuation upside.

**Spark’s Take on SERA Stock**

According to Spark, TipRanks’ AI Analyst, SERA is a Neutral.

The score is held down primarily by very weak financial performance (minimal/declining revenue, negative gross profit, and sustained losses with ongoing cash burn). It is partially offset by a supportive earnings-call backdrop (cash runway through 2029 and cost-reduction/commercial progress) and neutral-to-mildly positive near-term technical signals, while valuation remains constrained by loss-making metrics and no dividend.

To see Spark’s full report on SERA stock,  
 click here. 

**More about Sera Prognostics**

**YTD Price Performance:** -27.80%

**Average Trading Volume:** 69,600

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $83.41M

### Related Stocks

- [SERA.US](https://longbridge.com/en/quote/SERA.US.md)

## Related News & Research

- [Sera Prognostics CFO Scott Gleason files initial beneficial ownership statement](https://longbridge.com/en/news/297702357.md)
- [SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER | SERA Stock News](https://longbridge.com/en/news/296398026.md)
- [Sera Prognostics says PRIME trial shows PreTRM-guided care cuts preterm births before 32 weeks by over 50%](https://longbridge.com/en/news/296910866.md)
- [Hornbeck appoints Todd M. Hornbeck as CEO; William L. Transier named Chairman](https://longbridge.com/en/news/297698487.md)
- [Lottomatica agrees all-share merger with Cirsa](https://longbridge.com/en/news/297734469.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**